Found 3 hits for monomerid = 50390091 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Sodium channel protein type 9 subunit alpha
(Homo sapiens (Human)) | BDBM50390091
(CHEMBL2069423)Show SMILES COc1ncc(cn1)-c1cccc2OC[C@H](Cc12)NC(=O)c1ccc(COCC(F)(F)F)nc1 |r| Show InChI InChI=1S/C23H21F3N4O4/c1-32-22-28-9-15(10-29-22)18-3-2-4-20-19(18)7-17(12-34-20)30-21(31)14-5-6-16(27-8-14)11-33-13-23(24,25)26/h2-6,8-10,17H,7,11-13H2,1H3,(H,30,31)/t17-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 251 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human NaV1.7 expressed in HEK293 cells by whole-cell voltage clamp assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50390091
(CHEMBL2069423)Show SMILES COc1ncc(cn1)-c1cccc2OC[C@H](Cc12)NC(=O)c1ccc(COCC(F)(F)F)nc1 |r| Show InChI InChI=1S/C23H21F3N4O4/c1-32-22-28-9-15(10-29-22)18-3-2-4-20-19(18)7-17(12-34-20)30-21(31)14-5-6-16(27-8-14)11-33-13-23(24,25)26/h2-6,8-10,17H,7,11-13H2,1H3,(H,30,31)/t17-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.58E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by IonWorks HT assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |
Sodium channel protein type 5 subunit alpha
(Homo sapiens (Human)) | BDBM50390091
(CHEMBL2069423)Show SMILES COc1ncc(cn1)-c1cccc2OC[C@H](Cc12)NC(=O)c1ccc(COCC(F)(F)F)nc1 |r| Show InChI InChI=1S/C23H21F3N4O4/c1-32-22-28-9-15(10-29-22)18-3-2-4-20-19(18)7-17(12-34-20)30-21(31)14-5-6-16(27-8-14)11-33-13-23(24,25)26/h2-6,8-10,17H,7,11-13H2,1H3,(H,30,31)/t17-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human NaV1.5 expressed in CHO cells by IonWorks assay |
Bioorg Med Chem Lett 22: 5618-24 (2012)
Article DOI: 10.1016/j.bmcl.2012.06.105 BindingDB Entry DOI: 10.7270/Q2ZC83ZX |
More data for this Ligand-Target Pair | |